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Abstract
In Brazil, millions of prescriptions do not follow 
the legal requirements necessary to guarantee the 
correct dispensing and administration of medica-
tion. This multi-centre exploratory study aimed 
to analyze the appropriateness of prescriptions 
at four Brazilian hospitals and to identify pos-
sible errors caused by inadequacies. The sample 
consisted of 864 prescriptions obtained at hos-
pital medical clinics in January 2003. Data was 
collected by three nurse researchers during one 
week using a standard data sheet that included 
items about: the type of prescription; legibility; 
completeness; use of abbreviations; existence of 
changes and erasures. There were statistically sig-
nificant differences between incomplete electron-
ic prescriptions at hospital A, and handwritten 
ones from hospitals C (χ2 = 12.703 and p < 0.001) 
and D (χ2 = 14.074 and p < 0.001). Abbreviations 
were used in more than 80% of prescriptions at 
hospitals B, C and D. Changes were found in 
prescriptions at all hospitals, with higher levels 
at hospitals B (35.2%) and A (25.3%). This study 
identified a range of vulnerable points in the pre-
scription phase of the medication system at the 
hospitals. Physicians, pharmacists and nurses 
should therefore jointly propose strategies to 
avoid these prescription errors.
Medication Errors; Medication Systems; Drug 
Prescriptions
Introduction
Medication errors are a serious public health 
problem and have received a great deal of atten-
tion in recent years. Their effects can range from 
small injuries to the patient’s death and these 
errors can occur at any stage of the medication 
system. For these reasons, various studies have 
aimed to analyze medication systems, detect 
the most frequent problems, remove the focus 
from human caused errors and, above all, im-
prove patient safety 1,2. According to the National 
Coordinating Council for Errors in Medication 
Reporting and Prevention (NCCMERP) 3, a medi-
cation error is defined as any preventable event 
that may cause or lead to inappropriate medica-
tion use or patient harm while the medication is 
in control of the health care professional, patient 
or consumer.
Between 1983 and 1993, medication errors 
occurred in 5% of all hospital admissions in the 
United States. This same period saw a 257% in-
crease in drug-related deaths 4. The Institute of 
Medicine estimated that 7,000 Americans die an-
nually due to medication errors 5. In the United 
Kingdom, medication error is one of the most 
common causes of unintentional harm which re-
sults in an estimated 85,000 hospital admissions 
every year 6. These errors were responsible for 
approximately 5% of hospitalizations in Spain, 
with an average cost of 3,000 Euros per patient 7. 
Moreover, it is estimated that 80,000 incidents 
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and errors occur in Australia with costs of at least 
US$350 million per year 8.
In South America the situation is no different. 
An observational study carried out in Colombia 
between 1993 and 2006 demonstrated that the 
main types of medication errors caused death 
(45%) or harm (47.3%) to patients 9. In Argentina, 
two studies in public hospitals estimated that 
there are errors in two out of every ten medica-
tion indications 10. One study in Uruguay showed 
that the majority of resident doctors do not have 
sufficient knowledge about doses, adverse reac-
tions and contraindications of drugs 11.
The discussion about medication errors 
in Brazil is still incipient and few articles have 
been published 1,2,12,13. Medication errors ac-
counted for 50% of adverse events detected in 
a study carried out in a private hospital in the 
city of Campinas (São Paulo State) 14. In anoother 
study performed in a public hospital in the city of 
Belo Horizonte (Minas Gerais State), 82% of 422 
prescription order forms presented at least one 
dispensing error 15. Administrative errors repre-
sented about 27% of adverse events identified 
in a Brazilian multi-centre study 16. In 2001, the 
National Sanitary Surveillance Agency (ANVISA) 
created a project, called the Sentinel Hospitals, 
to reduce these problems and try to build a refer-
ence network for hospitals that will provide data 
on adverse events 2.
The medication system is multidisciplinary 
and includes prescribing, dispensing, adminis-
tering and monitoring. Although various health 
care providers are involved in this system, these 
processes should be harmonized to ensure pa-
tient safety. The medication system starts with 
the prescription. Any flaw at this stage can direct-
ly or indirectly lead to problems in subsequent 
stages, increase medication error statistics and 
affect patient safety.
According to Bobb et al. 17, the incidence of 
prescribing errors in the United States has been 
reported to range from three to 99 errors per 
1,000 inpatient medication orders. In Brazil, ev-
ery year, millions of prescriptions do not follow 
the legal requirements that are necessary to guar-
antee correct dispensing and administration of 
medication 18. Moreover, different studies have 
shown that the inadequacies of prescriptions 
and the difficulties in understanding them risk 
patient safety 1,15,19. Therefore, the aims of this 
study were to analyze the quality of prescriptions 
at four Brazilian hospitals and to identify pos-
sible errors caused by inadequacies.
Methodology
Study design
This multi-centre exploratory survey sought 
to collect detailed descriptions of the variables 
which are included in medical prescriptions at 
different Brazilian hospitals.
Settings
The research was carried out at the medical clin-
ics of four university hospitals located in Goiâ-
nia (Goiás State), Recife (Pernambuco State), 
Ribeirão Preto and São Paulo (both São Paulo 
State), described in the text as hospitals A, B, C 
and D, in which the sequence of letters does not 
correspond to the order of cities shown above.
The choice of these institutions was made 
because they are linked to state or federal public 
universities and they are part of the ANVISA Sen-
tinel Hospital Network. Furthermore, a Sentinel 
Hospital Network was created as a national net 
pilot test, which has more than 100 hospitals in-
volved. These hospitals were chosen for having 
a larger number of medical residence programs 
per state. Notification of adverse drug events is 
encouraged in order to gather as much informa-
tion as possible, so the government is able to reg-
ulate medicines and medical commerce 16.
The medical clinics were selected because 
they assign beds for patients with chronic-de-
generative diseases, whose treatment usually in-
volves a wide range of drugs over a long period 
of time.
Sample
The study sample consisted of 864 prescriptions 
for patients hospitalized at the medical wards, 
during one week in January 2003. From this total, 
110 were from hospital A, 108 from B, 294 from 
C and 248 from hospital D. All prescriptions ob-
served were used in the study and there were no 
exclusions.
Data collection procedures
After participating in 20 hours of training ses-
sions, three nurse researchers collected data at 
each of the hospitals. Data was collected in close 
proximity to the nursing staff and always at the 
end of the afternoon, during seven consecutive 
days 17,20,21 through a structured instrument de-
veloped by the group of researchers, based on the 
literature 22, with items about the type of medi-
cation prescription (electronic or handwritten), 
legibility (legible, illegible or partially printing), 
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completeness of prescriptions (complete or not 
complete), abbreviations (present or not present) 
and existence of changes and erasures. It is im-
portant to highlight that illegible prescriptions or 
unmarked items were not included in the other 
analysis.
The nurse researchers visited the wards to 
revise all prescriptions issued by physicians dur-
ing the morning, and filled out the standard data 
sheet.
Data analysis
The prescriptions were analyzed as follows: 
• Type of prescription: whether electronic or 
handwritten;
• Legibility: the difficulty in interpreting the 
content of prescriptions, according to all three re-
searchers, and requiring further clarification with 
the prescriber and/or a review of the charts 17. 
The electronic and handwritten prescriptions 
were classified as: legible, partially illegible and 
illegible. The researchers built a protocol based 
on the literature and Brazilian regulations to 
judge these prescriptions 18,23. During the data 
collection, the researchers tried to read the pre-
scriptions and discussed its legibility. Decisions 
were made by consensus; however, when con-
sensus couldn’t be reached, majority voting was 
applied;
• Completeness: the prescription was consid-
ered complete when the following criteria were 
all present: patient identification, presence of 
date (present or not present), prescriber signa-
ture; time indications (correct time, complete 
time, legible or without erasures), the name of 
the medicine, dosage form, route of administra-
tion and dose 18,24;
• Abbreviations: whether yes or no. The abbre-
viations were checked in relation to the: dosage 
form – comp (tablets), amp (flask), caps (cap-
sules); route of administration – VO (administe-
red orally), IV (intravenous); and units – IU (mg, g, 
mL, etc.);
• Changes: any modifications in items of pre-
scriptions were observed, such as: the name of 
the medicine, dosage form, route of administra-
tion, dose and duration of treatment;
• Erasures: were considered to be any item that 
negatively affected the understanding of pre-
scribed items, whether caused by erasures, over-
lapping, and use of correctors, tape or spatters.
Statistical analyses
The data was analyzed using SPSS 11.0 (SPSS Inc., 
Chicago, U.S.A.). Absolute frequencies were de-
scribed as percentages. Chi-square analysis was 
used to evaluate associations in different hospital 
characteristics (p < 0.001).
Ethical aspects
This study was approved by the Research Eth-
ics Committees and authorized by the directors 
of the four hospitals in the study. The purpose 
of the present work was neither to find out nor 
to identify the professional that committed the 
flaw, but to analyze and detect the prescription 
errors, making the medication system safer for 
its users. Therefore, the collected data was used 
exclusively by the researchers, guaranteeing the 
privacy of the information obtained.
Results
Although all prescriptions are produced elec-
tronically at hospital A, handwritten changes to 
existing medications and the inclusion of new 
drugs occurred in 22% of cases. This was possible 
because the computer system does not permit 
changes after the electronic prescription print-
out. Handwritten prescriptions were still used 
at the three other hospitals. Moreover, 12% of 
prescriptions at hospital B, 35.5% at hospital C 
and 12% at hospital D were considered fully or 
partially illegible, mainly due to the physician’s 
handwriting. At hospital C, for example, 7% of 
the 294 prescriptions examined were illegible 
and 28.5% partially illegible (Table 1).
It is important to highlight that the illegible 
prescriptions were not included in the other sta-
tistics. In this study, only hospital A used generic 
names for drugs in all prescriptions. The highest 
number of complete prescriptions was found at 
hospital D (38%).
Incomplete prescriptions were most com-
mon at hospital C (94.5%), followed by hospital 
B (88%). Also, there were statistically significant 
differences between hospital A, with electronic 
prescriptions, and C (c2 = 12.703 and p < 0.001) 
and D (c2 = 14.074 and p < 0.001).
Among more missed items, the dosage form 
was common in 87% of prescriptions at hospital 
B and 77% at C. Moreover, less than half of the 
prescriptions at hospitals A, C and D informed 
what medication doses were to be administered. 
Information about routes of administration was 
missing in 3.5% of prescriptions at hospital A 
and 5.5% at hospital C. Only at hospital B did all 
prescriptions contain information on dose and 
route of administration. Abbreviations were used 
in more than 80% of prescriptions at hospitals B, 
C and D, against 30% at hospital A. Most of these 
abbreviations were for routes of administration, 
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Table 1
Distribution of drug prescriptions analyzed per hospital and specifi cation of content characteristics, from December 2002 to January 2003.
 Specifications Hospitals
 A (n = 110) B (n = 108) C (n = 294) D (n = 248)
   n % n % n % n %
 1 – Legibility        
  Legible printing/written 108 98.0 95 88.0 190 64.5 219 88.0
  Illegible printing/written - - 3 3.0 20 7.0 2 1.0
  Partially illegible printing/written 2 2.0 10 9.0 84 28.5 27 11.0
 2 – Nomenclature    
  Brand name - - 1 1.0 121 41.0 92 37.0
  Generic name 110 100.0 1 1.0 - - 1 0.5
  Brand and generic name - - 106 98.0 172 58.5 155 62.5
 3 – Completeness of prescription    
  Complete 19 17.3 13 12.0 16 5.5 94 38.0
  Incomplete 91 82.7 95 88.0 278 94.5 154 62.0
 4 – Incomplete prescriptions: most missing items *    
  Dosage form 33 30.0 94 87.0 222 77.0 107 43.1
  Dose 49 44.5 - - 66 23.0 76 31.0
  Administration route 4 3.5 - - 19 5.5 - -
 5 – Abbreviations    
  Present 33 30.0 92 85.0 264 89.8 248 100.0
  Not present 70 63.5 16 15.0 16 5.4 - -
* The number of items does not correspond to the number of prescriptions, as one or more of the investigated items were missing in some prescriptions.
Note: p < 0.001.
such as EV (intravenous administration) and VO 
(oral administration), which were more frequent 
at hospitals C and D.
Changes were found in prescriptions at all 
hospitals, with higher levels at hospitals B (35.2%) 
and A (25.3%), followed by hospitals C (16.6%) 
and D (9.6%). The interruption of ongoing medi-
cation was most frequent at hospital B (35.2%). 
Other and less frequent alterations referred to 
substituted drugs, handwritten changes in po-
sology, time and routes of administration, as well 
as modifications in other items (Table 2).
At hospital A, 19% of prescriptions contained 
erasures, 12% at B, 29.9% at C and 16.9% at D, 
mainly in posology (8.3% at hospital B and 7.5% 
at C). This data showed that there were no statis-
tically significant differences between the hos-
pitals (c2 = 6.258, p = 0.745). Moreover, 100% of 
the electronic prescriptions in hospital A were 
frequently dated in comparison with about 96% 
of handwritten patient prescriptions, at B and C. 
At hospital D, 17% of prescriptions did not have 
a date.
Other analysis showed that all study hospi-
tals adopted an institutional standard to deter-
mine time indications, which was established by 
a clerk at hospital A, the nurse or nurse resident 
at B, a member of the nursing team at C and nurs-
ing auxiliaries at D. Correct times (100%), com-
plete times (98%) and legible time indications 
(99%) were most frequent at hospital B. The low-
est number of erasures in time indications was 
found at hospital D (91%).
Discussion
This study provides evidence that prescribing 
errors are common in different Brazilian hospi-
tals. The international literature describes that 
the implementation of an electronic prescrip-
tions system, as used in hospital A, brings im-
portant advantages to medication safety and it 
improves drugs logistics 20,21,25,26. According to 
Koppel et al. 27, the electronic prescription is one 
way of modernizing, simplifying and making 
the medication system safer, partially because it 
eliminates the problem of legibility, reduces er-
rors and provides greater safety for medication 
distribution and administration. These prescrip-
tions, credited with lowering medication errors 
by up to 81% eliminate mistakes due to illegible 
handwriting, and reduce the likelihood of er-
rors that stem from drugs with similar names 17. 
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However, some studies have demonstrated that 
an electronic prescription system can minimize 
but does not fully eliminate the possibility of er-
rors 19,20. These risks can increase when, in this 
study, the handwritten modifications were done 
to interrupt actual medications or to include new 
drugs. It is also expensive to establish such a sys-
tem, even by international standards, which is an 
impediment for a number of institutions.
On the other hand, at hospital B, the nurse or 
a clerk transcribed all prescriptions in the com-
puter in order to request the medication from 
the pharmacy. At hospitals C and D a copy of the 
physician’s handwritten prescription was sent to 
the pharmacy, while the original was kept inside 
the patient’s records. Although this system can 
avoid transcription errors, the copy handled by 
the pharmacy is not always legible. According to 
the literature, this practice causes serious risks of 
dose errors, route and dosage form, for example, 
as illegible handwriting may, in the worse case 
scenario, lead to a patient’s death 22,28. In almost 
all cases, errors caused by illegible handwritten 
prescriptions could be preventable, thus, efforts 
from universities and ANVISA are necessary to 
qualify prescribers and eliminate this problem 
from the Sentinel Hospitals Network.
When the presence of a generic name in pre-
scriptions was analyzed, the present study find-
ings show that only hospital A complies with the 
obligation of using it, mainly due to the use of an 
electronic prescription system, although the use 
of generic medication names is obligatory on all 
prescriptions issued in the Brazilian Unified Na-
tional Health System (SUS).
In view of similar names, labels and packages, 
the lack of a standard for using generic or brand 
names is an important risk factor that can lead to 
a series of errors in the subsequent stages of the 
medication system 29. At the same time, prescrib-
ing commercial brands makes treatment more 
expensive. This is a relevant fact, as high drug 
costs have been indicated as the cause of omis-
sion errors and as a limiting factor for medication 
treatment adherence, mainly in middle-income 
countries such as Brazil 19,20. The literature men-
tions the use of both generic and brand names as 
the most advisable and safe approach to avoiding 
system errors 29.
According to the results, missing items 
were another common problem observed in 
prescriptions. The international and national 
standards recommend that all prescriptions 
clearly include important information such as 
the dosage form, dose and route of administra-
tion 18,24. When prescriptions are not complete, 
it may cause serious risks to patient safety. In 
this study, few prescriptions analyzed contained 
the correct and complete specifications, which 
are paramount for treatment success. These 
Table 2
Distribution of drug prescriptions in terms of changes made, date and timing, from December 2002 to January 2003.
 Changes and types Hospitals
 A B C D
   n % n % n % n %
 1 – Types of changes    
  Interrupted medication 12 10.9 38 35.2 5 1.7 16 6.4
  Replaced medication - - - - 44 14.9 6 2.4
  Changes in administration route - - - - - - 2 0.8
  Handwritten modifications to dose 4 3.6 - - - - - -
  Handwritten modifications to time 3 2.7 - - - - - -
  Handwritten modifications to other prescription items 9 8.1 - - - - - -
 2 – Presence of date    
  Present 110 100.0 103 95.4 284 96.6 205 82.7
  Not Present - - 5 4.6 3 1.0 43 17.3
 3 – Time indications    
  Correct time 98 89.9 108 100.0 295 93.5 236 95.1
  Complete time 107 92.7 106 98.1 269 91.5 235 94.7
  Legible 106 96.3 107 99.0 265 90.1 203 81.8
  Without erasures 96 87.2 84 77.7 255 86.7 226 91.1
Note: p < 0.001.
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findings corroborate other previous studies and 
demonstrate the need to restructure the medi-
cation process to avoid omission of information 
in prescriptions 30,31. The literature affirms that 
most hospitals do not have a computerized phy-
sician order entry system yet, and for this rea-
son the incorporation of the pharmacist into the 
health care team is a more feasible alternative 
to checking prescription completeness to avoid 
these errors 14,30,31.
All hospitals, in this study, permitted the 
use of abbreviations. Although it saves time and 
space, using abbreviations may sometimes turn 
out to be very expensive, as they may be misinter-
preted, have double meanings, be confusing and 
give rise to errors 32,33,34. Some studies mentioned 
difficulties in making the following distinctions 
on handwritten prescriptions: comp (tablets) vs. 
amp (flask); caps (capsules) vs. comp (tablets); sup 
(suppositories) vs. susp (suspension), which can 
lead to incorrect routes of administration and/or 
techniques 19,31,35. In 2007, ANVISA discussed the 
establishment of standards for abbreviations in 
prescriptions 36. Hence, prescribers should avoid 
frequent abbreviations and, if necessary, only use 
standardized versions 37,38. Moreover, electronic 
prescriptions can also eradicate the use of ab-
breviations 21.
As mentioned in the above results, handwrit-
ten changes in electronic prescriptions were ob-
served at hospital A. Gimenes et al. 20 described 
that doctors and residents pointed out the dif-
ficulty of introducing new information as a dis-
advantage of electronic prescriptions. Koppel et 
al. 27 recognized that the inflexibility of electronic 
prescriptions, with regard to any kind of non-
standard changes, can generate new error risks. 
The interruption of prescriptions was the most 
common change found in this study and it oc-
curred at all hospitals, including hospital A. This 
data was confirmed by the literature that dem-
onstrated that interruptions of the drug regimen 
were not reduced by electronic prescriptions 35,39. 
So, Lesar 28 highlighted the need to confirm pre-
scription changes or interruptions, from the dis-
cussion between the pharmacist and physician.
Also, the results showed that there were no 
statistically significant differences between era-
sures made at the prescriptions in all hospitals 
(p < 0.001). It may cause confusion, which goes 
against the Brazilian medical ethics code which 
establishes that the doctor is responsible for pre-
scribing clearly and legibly and, therefore, without 
erasures 40. Despite this, previous studies showed 
that erasures are common in Brazilian prescrip-
tions 13,20,35. Sometimes a ‘free text’ feature can 
be used to substitute erasures in prescriptions. 
However, this alternative has to be evaluated by 
the pharmacist or nurse for both logistical and 
safety reasons 26.
Analyzing the inclusion of dates in Brazilian 
hospital prescriptions, the results differ from 
another study, carried out in a walk-in clinic, 
where only 47% of handwritten prescriptions 
were dated 19. The omission of this information 
may cause the interruption of drug administra-
tion before the foreseen treatment duration. In 
the case of antibiotics, for instance, the interrup-
tion before the foreseen treatment duration may 
cause bacterial resistance and the inability to use 
subsequently the same antimicrobial agent 30.
Researchers in this area reject approaches that 
focus on health care providers as the single cause 
of errors and assert that systematic changes are 
the most effective strategy to reduce the proba-
bility of accidents 41,42. Based on this, nurses and 
pharmacists, although they are not directly re-
sponsible for prescribing drugs, should know all 
aspects and phases involved in the process, col-
laborating with physicians to prevent errors that 
negatively affect the patients 26. Moreover, these 
health care providers can be considered jointly 
responsible for ensuring patient safety 28.
Study limitations
There were several limitations to our study. It was 
conducted over a 1-week period in four Sentinel 
Hospitals. These results may not be generaliz-
able to other hospital settings where there are no 
medical residency programs. There is a chance 
that during this week prescribing errors occurred 
more frequently than they occur on average. The 
study was not designed or powered to identify 
differences in the types of errors. Future works 
should be designed to focus on these differences.
Conclusions
This study demonstrates that most prescriptions 
from four hospitals investigated were inadequate 
in terms of legibility, use of abbreviations and 
omitted items, entailing serious risks for patient 
safety. The gravity of this situation is worsened 
by the fact that the four hospitals are referral in-
stitutions in the SUS and, mainly, responsible for 
training future health care providers.
We identified a range of vulnerable points 
in the prescription phase of the medication sys-
tem at the study hospitals. Therefore, physicians, 
pharmacists and nurses should work together, 
discuss and propose strategies to avoid the most 
common prescription errors, contributing to the 
structure of a safer medication system for Brazil-
ian patients.
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Resumo
No Brasil, milhões de prescrições não apresentam os 
requisitos legais necessários para garantir a correta 
dispensação e administração dos medicamentos. Este 
estudo multicêntrico exploratório objetivou anali-
sar a adequação das prescrições em quatro hospitais 
brasileiros e identificar eventuais erros causados pelas 
inadequações. A amostra consistiu de 864 prescrições 
obtidas nas clínicas médicas dos hospitais em janei-
ro de 2003. Os dados foram coletados por três enfer-
meiras durante uma semana através de instrumento 
estruturado com variáveis sobre: tipo de prescrição; 
legibilidade; completude; presença de abreviações, al-
terações e rasuras. Houve diferenças estatisticamente 
significativas entre prescrição eletrônica no hospital 
A e manuscritas nos C (χ2 = 12,703 e p < 0,001) e D 
(χ2 = 14,074 e p < 0,001). Abreviações foram usadas em 
mais de 80% das receitas nos hospitais B, C e D. Alte-
rações foram encontradas em prescrições de todos os 
hospitais, com níveis mais elevados no B (35,2%) e A 
(25,3%). Este estudo identificou uma série de pontos 
vulneráveis na fase prescrição dos sistemas de medi-
cação dos hospitais. Portanto, médicos, farmacêuticos 
e enfermeiros deverão juntos propor estratégias para 
evitar erros de prescrição.
Erros de Medicação; Sistemas de Medicação; Prescrição 
de Medicamentos
Contributors
A. I. Miasso, R. C. Oliveira, F. T. Fakih and A. E. B. C. Silva 
were responsible for gathering, analyzing and interpret-
ing the data; as well as revising the article and for the 
final approval of the version to be published. D. P. Lyra 
Junior and F. R. E. Gimenes were responsible for inter-
pretation of the data, drafting the article and for the 
final approval of the version to be published. S. H. B. 
Cassiani was the coordinator of the multi-centre study, 
assisting the gathering, analysis and interpretation of 
data and was responsible for the final approval of the 
version to be published.
Acknowledgments
The authors wish to thank the Brazilian Council for 
Scientific and Technological Development (CNPq) and 
the São Paulo State Research Foundation (FAPESP) for 
financial support.
References
1. Carvalho VT, Cassiani SHB, Chiericato C, Miasso AI. 
Erros mais comuns e fatores de risco na adminis-
tração de medicamentos em unidades básicas de 
saúde. Rev Latinoam Enferm 1999; 7:67-75.
2. Rosa MB, Perini E. Erros de medicação: quem foi? 
Rev Assoc Med Bras 2003; 49:335-41.
3. National Coordinating Council for Medication Er-
ror Reporting and Prevention. What is medication 
error? http://www.nccmerp.org/council/coun
cil1996-09-04.html (accessed on 14/Sep/2005).
4. Bond CA, Raehl CL, Franke T. Medication errors 
in United States hospitals. Pharmacotherapy 2001; 
21:1023-36.
5. Kohn LT, Corrigan JM, Donaldson MS, editors. In-
stitute of Medicine report. To err is human: build-
ing a safer health system. Washington DC: National 
Academies Press; 1999.
6. Timbs O. Leading role for pharmacists to reduce 
drug errors and improve patient safety. Pharm J 
2002; 268:39.
7. Otero-López MJ. Nuevas iniciativas para mejorar 
la seguridad de la utilización de los medicamen-
tos en los hospitales. Rev Esp Salud Pública 2004; 
78:323-39.
8. Roughead EE. The nature and extent of drug-relat-
ed hospitalisations in Australia, 1999. J Qual Clin 
Pract 1999; 19:19-22.
9. Paredes NM, Parras MEO. Errores de medicación 
en los profesionales sanitarios y sus consecuen-
cias médico legales. Rev Méd Legal 2006; 13:24-9.
11. Giachetto G, Banchero P, Telechea H, Speranza N, 
Wolaj M, Toledo M, et al. Uso racional de medica-
mentos: ¿qué conocen los médicos residentes so-
bre los fármacos de uso corriente? Rev Med Urug 
2003; 19:231-6.
12. Kawano DF, Pereira LRL, Ueta JM, Freitas O. Aci-
dentes com os medicamentos: como minimizá-
los? Rev Bras Ciênc Farm 2006; 42:487-95.
13. Miasso AI, Grou CR, Cassiani SHB, Silva AEBC, 
Fakih FT. Erros de medicação: tipos, fatores cau-
sais e providências tomadas em quatro hospitais 
brasileiros. Rev Esc Enferm USP 2006; 40:524-32.
Miasso AI et al.320
Cad. Saúde Pública, Rio de Janeiro, 25(2):313-320, fev, 2009
14. Monzani AAS. A ponta do iceberg: o método de 
notificação de erros de medicação em um hospital 
geral privado no município de Campinas-SP [Dis-
sertação de Mestrado]. Escola de Enfermagem de 
Ribeirão Preto, Universidade de São Paulo; 2006.
15. Anacleto TA, Perini E, Rosa MB, César CC. Drug-
dispensing errors in the hospital pharmacy. Clinics 
2007; 62:243-50.
16. Miasso AI, Silva AEBC, Cassiani SHB, Grou CR, Oli-
veira RC, Fakih FT. O processo de preparo e admi-
nistração de medicamentos: identificação de pro-
blemas para propor melhorias e prevenir erros de 
medicação. Rev Latinoam Enferm 2006; 14:354-63.
17. Bobb A, Gleason K, Husch M, Feinglass J, Yarnold 
PR, Noskin GA. The epidemiology of prescrib-
ing errors: the potential impact of computerized 
prescriber order entry. Arch Intern Med 2004; 
164:785-92.
18. Ministério da Saúde. Lei nº. 5.991. Dispõe sobre o 
controle sanitário do comércio de drogas, medica-
mentos, insumos farmacêuticos e correlatos, e dá 
outras providências. Diário Oficial da União 1973; 
17 jan.
19. Lyra Junior DP, Prado MCTA, Abriata JP, Pelá IR. 
Prescription orders as cause of risk of drug-related 
problems. Seguim Farmacoter 2004; 2:86-96.
20. Gimenes FRE, Miasso AI, Lyra Junior DP, Grou CR. 
Electronic prescription as contributory factor for 
hospitalized patients’ safety. Pharmacy Practice 
2006; 4:13-7.
21. Shulman R, Singer M, Goldstone J, Bellingan G. 
Medication errors: a prospective cohort study of 
hand-written and computerised physician order 
entry in the intensive care unit. Crit Care 2005; 9:
R516-21.
22. Lisby M, Nielsen LP, Mainz J. Errors in the medica-
tion process: frequency, type, and potential. Int J 
Qual Health Care 2005; 17:15-22.
23. Organização Mundial da Saúde. Guia do instrutor 
em práticas da boa prescrição médica. Genebra: 
Organização Pan-Americana da Saúde; 2001.
24. National Coordinating Council for Medication 
Error Reporting and Prevention. Recommenda-
tions to enhance accuracy of prescription writing, 
2005. http://www.nccmerp.org (accessed on 12/
Nov/2007).
25. Fontan JE, Maneglier V, Nguyen VX, Loirat C, Brion 
F. Medication errors in hospitals: computerized 
unit dose drug dispensing system versus ward 
stock distribution system. Pharm World Sci 2003; 
25:112-7.
26. Kalmeijer MD, Holtzer W, van Dongen R, Guche-
laar HJ. Implementation of a computerized phy-
sician medication order entry system at the Aca-
demic Medical Centre in Amsterdam. Pharm World 
Sci 2003; 25:88-93.
27. Koppel R, Metlay JP, Cohen A, Abaluck B, Localio AR, 
Kimmel SE, et al. Role of computerized physician 
order entry systems in facilitating medication er-
rors. JAMA 2005; 293:1197-203.
28. Lesar TS. Medication prescribing error reporting 
and prevention program: a 14-year experience. 
Medscape Pharmacists 2000; 1:1-28.
29. Cohen MR. Preventing medications errors related 
to prescribing. In: Cohen MR, editor. Medication 
errors causes, prevention, and risk management. 
Washington DC: American Pharmaceutical Asso-
ciation; 2000. p. 88.1-8.23.
30. Louro E, Romano-Lieber NS, Ribeiro E. Eventos 
adversos a antibióticos em pacientes internados 
em um hospital universitário. Rev Saúde Pública 
2007; 41:1042-8.
31. Vaida AJ, Peterson J. Incomplete directions can 
lead to dispensing errors. Pharmacy Times 2002; 
5:34-8.
32. Scarsi KK, Fotis MA, Noskin GA. Pharmacist par-
ticipation in medical rounds reduces medication 
errors. Am J Health Syst Pharm 2002; 59:2089-92.
33. Davis NM. Medical abbreviations: 15,000 conve-
niences at the expense of communications and 
safety. Huntington Valley: Neil M. Davis Associates; 
2001.
34. Benjamin DM. Reducing medication errors and 
increasing patient safety: case studies in clinical 
pharmacology. J Clin Pharmacol 2003; 43:768-83.
35. Cassiani SHB, Freire CC, Gimenes FRE. A prescri-
ção médica eletrônica em um hospital universitá-
rio: falhas de redação e opiniões de usuários. Rev 
Esc Enferm USP 2003; 37:51-60.
36. Agência Nacional de Vigilância Sanitária. Consulta 
pública nº. 50. Dispõe sobre o Vocabulário Contro-
lado de Formas Farmacêuticas. Diário Oficial da 
União 2007; 30 mai.
37. Joint Commission on Accreditation of Healthcare 
Organizations. National patient safety goals for 
2006. http://www.jointcommission.org/General
Public/NPSG/06_gp_npsg.htm (accessed on 22/
May/2006).
38. Institute for Safe Medication Practices. Special is-
sue: do not use these dangerous abbreviations or 
dose designations, 2005. http://www.ismp.org/
Newsletters/acutecare/articles/20030220_2.asp 
(accessed on 12/Nov/2007).
39. Pedersen CA, Schneider PJ, Scheckelhoff DJ. ASHP 
National Survey of Pharmacy Practice in Hospital 
Settings: prescribing and transcribing – 2004. Am J 
Health-Syst Pharm 2005; 62:378-90.
40. Conselho Federal de Medicina. Código de ética 
médica, 1998. http://www.portalmedico.org.br/
index.asp?opcao=codigoetica&portal (acessed on 
12/Jan/2007).
41. Bates DW, Teich J, Lee J, Seger D, Kuperman G, 
Maluf N, et al. The impact of computerized physi-
cian order entry on medication error prevention. J 
Am Med Inform Assoc 1999; 6:313-21.
42. Kaushal R, Barker KN, Bates DW. How can infor-
mation technology improve patient safety and re-
duce medication errors in children’s health care? 
Arch Pediatric Adolesc Med 2001; 55:1002-6.
Submitted on 15/Aug/2006
Final version resubmitted on 04/Mar/2008
Approved on 24/Mar/2008
